FDA Law Update

FDA Announces Plans to Resume Domestic On-site Inspections

July 16, 2020

FDA Law Update

FDA Issue Guidance on Manufacturing Drugs, APIs during COVID-19

June 25, 2020

FDA Law Update

Navigating FDA Policies for PPE, and Liability Protections

June 12, 2020

Healthcare Law Blog

Going Virtual: Clinical Trials, Telemedicine, Electronic Medical Records, And All That.

June 8, 2020

FDA Law Update

FDA Updates Policy to Curb Unreliable COVID-19 Antibody Tests

May 6, 2020

FDA Law Update

Upping Hospitals’ Liability Defenses For COVID Measures

April 14, 2020

FDA Law Update

April 16 Update: Key FDA Actions for COVID-19 Devices and Therapies

April 14, 2020

FDA Law Update

Update: Key FDA Actions for COVID-19 Devices and Therapies

April 8, 2020

FDA Law Update

Personal Protective Equipment & Ventilators: How FDA Is Increasing Supply for the US Healthcare System

March 31, 2020

Healthcare Law Blog

FDA Grants COVID-19 Diagnostic Emergency Use Authorizations, And Other Recent FDA Actions to Address COVID-19

March 16, 2020

FDA Law Update

FDA Grants COVID-19 Diagnostic Emergency Use Authorizations, And Other Recent FDA Actions to Address COVID-19

March 16, 2020

FDA Law Update

FDA Postpones Ex-US Facility Inspections

March 11, 2020

FDA Law Update

How FDA is Reacting to the Coronavirus, and 2020 Regulatory Priorities

March 5, 2020

Healthcare Law Blog

FDA Year in Review: A Shifting Regulatory Landscape

January 15, 2020

FDA Law Update

FDA Year in Review: A Shifting Regulatory Landscape

January 7, 2020